[Simvastatin, an additional drug against breast cancer?]

Med Sci (Paris). 2022 Aug-Sep;38(8-9):646-647. doi: 10.1051/medsci/2022095. Epub 2022 Sep 12.

[Article in French]

Authors

Hong Li¹, Catherine Buquet¹, Jean-Pierre Vannier¹, Souleymane Abdoul-Azize¹

Affiliation

¹ Inserm UMR1234, université de Rouen, Institut de recherche et d'innovation en biomédecine, faculté de médecine et pharmacie, Rouen, France.

PMID: 36094232
DOI: 10.1051/medsci/2022095

No abstract available

Publication types

News

MeSH terms

Breast Neoplasms* / drug therapy
Cell Line, Tumor
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / pharmacology
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Simvastatin / pharmacology
Simvastatin / therapeutic use

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Simvastatin